Pfenex
PFNX

From March 31, 2020 to June 30, 2020 Exercise of stock options

From December 31, 2019 to March 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock, net of discount and offering costs

from December 31, 2018 to December 31, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan

from June 30, 2019 to September 30, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan

from March 31, 2019 to June 30,2019 Exercise of stock options

from December 31, 2018 to March 31, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan

from December 31, 2017 to December 31, 2018 Restricted stock units Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock, net of discount and offering costs

from December 31, 2016 to September 30, 2017 Exercise of stock options Issuance of common stock under employee stock purchase plan

from December 31, 2015 to December 31, 2016 Exercise of stock options Issuance of common stock under employee stock purchase plan

From December 31, 2014 to December 31, 2015 Exercise of stock options ESPP – issuance of stock Issuance of common stock, net of discount

from December 31, 2013 to December 31, 2014 Conversion of preferred stock to common stock Exercise of stock options Preferred stock dividends paid in common shares Issuance of common stock, net of discount Repurchase of common stock Common stock forfeiture the Company issued 1,217,784 shares of common stock as payment of all accrued and unpaid dividends through July 28, 2014 On June 27, 2014, we effected a 2.812-for-1 reverse stock split of our outstanding common and preferred stock.

the Company issued 1,217,784 shares of common stock as payment of all accrued and unpaid dividends through July 28, 2014

the conversion of all outstanding shares of the company's redeemable convertible preferred stock, or the company's convertible preferred stock, into an aggregate of 8,634,847 shares of common stock immediately prior to the completion of this offering (which assumes the filing of a certificate of amendment to the company's amended and restated certificate of incorporation to change the conversion ratio of the company's Series A-1 Preferred Stock to approximately 0.91966 and the conversion ratio of the company's Series A-2 Preferred Stock to approximately 1.1406) the issuance of 1,217,784 shares of common stock in connection with the payment of all accrued and unpaid dividends through July 28, 2014 upon the conversion of the company'sconvertible preferred stock to common stock immediately prior to the completion of this offering, and based on the initial public offering price of $6.00 per share and the offering closing on July 29, 2014; the repurchase of 423,185 shares of the company's common stock at a purchase price of $0.31 per share in connection with the completion of this offering, pursuant to the amended and restated subscription agreement, dated May 2, 2014, entered into with certain stockholders, including Signet Healthcare Partners Accredited Partnership III, LP and Signet Healthcare Partners QP Partnership III, LP; the forfeiture of an aggregate of 100,000 shares of common stock by members of the company's management team in connection with the completion of this offering;

from December 31, 2013 to June 30, 2014 Exercise of stock options On June 27, 2014, we effected a 2.812-for-1 reverse stock split of our outstanding common and preferred stock.

from December 31, 2013 to March 31, 2014 Exercise of stock options